FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

Endocrinologic and Metabolic Drugs Advisory Committee Roster

Applying for Membership on FDA Advisory Committees

As part of the Food and Drug Administration's (FDA's) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees.

Current Number of Vacancies = 2
Note, one or more vacancies may be in the nomination process or a final appointment may have been made.

 


Chair
Vacant

Designated Federal Official
Paul Tran, B.S., Pharm., R.Ph.
Advisors and Consultants Staff  HFD-21
Center for Drug Evaluation and Research
Food and Drug Administration
5600 Fishers Lane
Rockville, Maryland  20857
Email: Paul.Tran@fda.hhs.gov
(301) 827-7001
FAX (301) 827-6776

Thomas P. Bersot, M.D., Ph.D.
Expertise:  Blood Lipid Disorders, CAD
Term:  11/2/2007 – 06/30/2011
Associate Investigator
Gladstone Institute of Cardiovascular Disease
1650 Owens Street
San Francisco, CA 94158-2261

Kenneth D. Burman, M.D. CV
Expertise: Endocrinology and Thyroid Disease
Term: 07/10/2006 - 06/30/2010
Chief, Endocrine Section
Washington Hospital Center
110 Irving Street, N.W.
2A72
Washington, DC 20010

Eric Felner, M.D.
Expertise: Pediatric Endocrinology
Term: 03/27/2008 – 06/30/2009
Emory University School of Medicine
Department of Pediatrics
2015 Uppergate Drive, NE
Atlanta, Georgia 30322

Katherine M. Flegal, Ph.D.
Expertise: Obesity and Epidemiology
Term: 07/10/2006 - 06/30/2010
Senior Research Scientist
Distinguished Consultant
National Center for Health Statistics
Centers for Disease Control and Prevention
3311 Toledo Road, Room 4311
Hyattsville, Maryland 20782

Allison B. Goldfine, M.D.
Expertise:  Diabetes and Endocrinology
Term: 11/2/2007 - 06/30/2011
Assistant Director of Clinical Research
Joslin Diabetes Center, Research Division
One Joslin Place, Room 655
Boston, MA 02215

*Jessica W. Henderson, Ph.D. CV
Expertise: Public Health Education
Term: 07/10/2006 - 06/30/2009
Associate Professor
Division of Health and Physical Education
Western Oregon University
345 N. Monmouth Avenue
Building NP, Room 208
Monmouth, Oregon 97361

 

Michael A. Proschan, Ph.D. CV
Expertise: Biostatistics
Term: 07/10/2006 - 06/30/2010
Biostatistician
Biostatistics Research Branch
National Institute of Allergy and Infectious Diseases
National Institutes of Health
6700A Rockledge Drive, Room 5140
Bethesda, Maryland 20892-7609

Clifford J. Rosen, M.D.
Expertise: Metabolic Bone Disease and Osteoporosis
Term: 07/01/2006 - 06/30/2010
Senior Staff Scientist
Maine Center for Osteoporosis
St. Joseph Hospital
900 Broadway, Building #2, Suite A
Bangor, Maine 04401

Abraham Thomas, M.D.
Expertise : Endocrinology
Term : 3/27/2008 – 06/30/2011
Division Head, Endocrinology, Diabetes, Bone and Mineral Disorders
Whitehouse Chair of Endocrinology
3031 W. Grand Boulevard, Suite 800
Detroit, Michigan 48202

**Enrico Veltri, M.D.
Expertise: Industry Representative
Term: 05/12/2008 – 10/31/2011
Group Vice President
Global Clinical Development
Cardiovascular and Metabolic Diseases
Schering-Plough Research Institute
2015 Galloping Hill Road
K-15-3-3005
Kenilworth, New Jersey 07033

 

 

 

 

 

 

 


PDF requires the free Adobe Acrobat Reader

* Consumer Representative
** Industry Representative

arrow Back to Top   arrow Back to Endocrine and Metabolic Drugs Advisory Committee Info

  Human Drug Advisory Committee Information

Date created: July 22, 2003, Updated: January 8, 2009

horizonal rule